logo
welcome
Insider

Insider

Moderna stock tumbles 21% as earnings show people aren't getting as many COVID shots

Insider
Summary
Nutrition label

81% Informative

Sales of its COVID-19 vaccine dropped 37% year-over-year in the second quarter .

Moderna lowered its annual sales forecast for the year to between $3 billion and $3.5 billion .

Shares of Moderna fell as much as 21% on Thursday as a result.

VR Score

86

Informative language

89

Neutral language

53

Article tone

semi-formal

Language

English

Language complexity

48

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

Source diversity

1

Affiliate links

no affiliate links